Profound Medical Corp has seen a notable increase in its stock price, closing up 7.28% in the last trading session.
In a strong trading session, Profound Medical Corp (PRN.TO) experienced a significant rise in its stock price, closing at CA$10.46. This 7.28% increase shows growing investor confidence in the company’s innovative medical technologies and recent financial performance.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeMarket cap
$348.84M
52W high
$12.40
52W low
$5.23
1W change
-1.60%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 154.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+154.9% Upside
Current Price
C$9.82
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
40.6%
Annualized
90-Day Vol
57.5%
Annualized
Trend (90d)
+11.7%
Annualized drift
90d Mean
C$10.24
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.96 | C$8.66 – C$11.45 |
| 60 trading days | C$10.10 | C$8.28 – C$12.31 |
| 90 trading days | C$10.24 | C$8.03 – C$13.05 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: For Canadian investors, Profound Medical's upward trend may indicate strong market potential, especially after their impressive revenue growth announcements.
7.28% Increase in Stock Price
Profound Medical Corp's stock gained CA$0.71, closing at CA$10.46, reflecting strong market interest and investor confidence.
Bull case
The company recently reported an impressive 104% revenue growth in Q1 2026, which likely boosted investor optimism. With Humana now covering the TULSA Procedure™, the market is reacting positively to the wider acceptance of Profound's technology.
Bear case
Despite the positive momentum, investors should stay cautious. The company has a history of operating losses, with a profit margin of -2.0676, which could pose risks if growth expectations aren’t met.
Strong Financial Performance
Profound Medical's recent financial results have been strong, with a 104% revenue growth reported for Q1 2026. This robust performance can significantly boost investor confidence and attract new capital into the stock. This growth is supported by the increasing adoption of their TULSA Procedure™, which is now covered by major insurance providers like Humana.
Market Reactions and Future Outlook
The stock's rise reflects positive market sentiment towards Profound Medical Corp. Investors are closely watching how the company will use its recent financial successes to maintain growth. However, potential investors should also keep in mind the company's history of operating losses, which could affect future performance. For more details on the company's financials, check out our Profound Medical Corp stock page.
Advertisement
